SHIVNAAM TRADELINK LLP. is a part of Eminent group of companies whose inception dates back to 2022. SHIVNAAM TRADELINK LLP. is reputed and leading merchant exporters in India of an extensive range of pharmaceuticals (mainly Gastroenterology, Hepatology, Virology, Oncology, Gynaecology and other specialized products) to USA, Russia, African, Gulf, European, & South East Asian countries. We are also engaged in wholesale distribution throughout India of specialized pharmaceuticals (mainly Gastroenterology, Hepatology, Virology, Oncology, Gynaecology and other specialized products) manufactured by reputed Indian & Multinational companies.

The Pharmaceutical range exported and traded by us includes products of the highest international quality manufactured by various Multinational companies and the most highly reputed Indian pharmaceutical companies. All our products are genuine and preserved in proper storage conditions as recommended by the manufacturers.

We offer the most competitive prices for all our products. Our company policy is to provide our best service to all our customers at all times. We maintain the highest standards of business ethics and financial discipline.

Since our inception we have persistently endeavoured to progressively improve the quality of service we provide to our customers, to increase our customer base, and to expand our range of pharmaceutical products.
Our efforts have helped us to expand our business in terms of geographical territory, customer base, and product range with resultant progressive growth in our sales turnover, and more importantly we have achieved excellent market reputation and an immaculate track record of very high business ethics and financial discipline.

We have the brightest people in the industry and believe that their diverse experiences and perspectives help to bring out our best ideas, drive innovation and achieve transformative business results.

We are proud of the advancements we have made in Gastroenterology, Hepatology, oncology, Haematology, immunology and cardiovascular disease, and we are dedicated to helping patients prevail over serious diseases through our diverse and promising pipeline and new scientific platforms. We are pursuing therapies at the forefront of scientific discovery with the goal of bringing an exciting new generation of life-changing treatments to patients. We aspire to be at the centre of a vibrant healthcare innovation ecosystem, where academic research centres, biotech and biopharma companies all contribute to continued scientific advancement.

As global citizens, we work sustainably and responsibly to create a positive impact in the communities where we live and work. We conduct our global business with the utmost integrity and transparency. We support programs, initiatives and organizations that help improve health, expand research opportunities, promote and expand education and deliver basic human services to our communities.

We know that our responsibility goes beyond medicine. We promote health equity globally and strive to increase access to life-saving medicines for populations disproportionately affected by serious diseases and conditions.